Modulation of insulin degrading enzyme activity and liver cell proliferation
Diabetes mellitus type 2 (T2DM), insulin therapy, and hyperinsulinemia are independent risk factors of liver cancer. Recently, the use of a novel inhibitor of insulin degrading enzyme (IDE) was proposed as a new therapeutic strategy in T2DM. However, IDE inhibition might stimulate liver cell prolife...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
17 Jun 2015
|
| In: |
Cell cycle
Year: 2015, Jahrgang: 14, Heft: 14, Pages: 2293-2300 |
| ISSN: | 1551-4005 |
| DOI: | 10.1080/15384101.2015.1046647 |
| Online-Zugang: | Verlag, teilw. kostenfrei, Volltext: http://dx.doi.org/10.1080/15384101.2015.1046647 Verlag, teilw. kostenfrei, Volltext: https://doi.org/10.1080/15384101.2015.1046647 
|
| Verfasserangaben: | Olga Pivovarova, Christian von Loeffelholz, Iryna Ilkavets, Carsten Sticht, Sergei Zhuk, Veronica Murahovschi, Sonja Lukowski, Stephanie Döcke, Jennifer Kriebel, Tonia de las Heras Gala, Anna Malashicheva, Anna Kostareva, Johan F. Lock, Martin Stockmann, Harald Grallert, Norbert Gretz, Steven Dooley, Andreas F.H. Pfeiffer, and Natalia Rudovich |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1567859127 | ||
| 003 | DE-627 | ||
| 005 | 20230427155631.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180130s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/15384101.2015.1046647 |2 doi | |
| 035 | |a (DE-627)1567859127 | ||
| 035 | |a (DE-576)497859122 | ||
| 035 | |a (DE-599)BSZ497859122 | ||
| 035 | |a (OCoLC)1340986176 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Pivovarova-Ramich, Olga |d 1979- |e VerfasserIn |0 (DE-588)1150988290 |0 (DE-627)1011201402 |0 (DE-576)497349884 |4 aut | |
| 245 | 1 | 0 | |a Modulation of insulin degrading enzyme activity and liver cell proliferation |c Olga Pivovarova, Christian von Loeffelholz, Iryna Ilkavets, Carsten Sticht, Sergei Zhuk, Veronica Murahovschi, Sonja Lukowski, Stephanie Döcke, Jennifer Kriebel, Tonia de las Heras Gala, Anna Malashicheva, Anna Kostareva, Johan F. Lock, Martin Stockmann, Harald Grallert, Norbert Gretz, Steven Dooley, Andreas F.H. Pfeiffer, and Natalia Rudovich |
| 264 | 1 | |c 17 Jun 2015 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 30.01.2018 | ||
| 520 | |a Diabetes mellitus type 2 (T2DM), insulin therapy, and hyperinsulinemia are independent risk factors of liver cancer. Recently, the use of a novel inhibitor of insulin degrading enzyme (IDE) was proposed as a new therapeutic strategy in T2DM. However, IDE inhibition might stimulate liver cell proliferation via increased intracellular insulin concentration. The aim of this study was to characterize effects of inhibition of IDE activity in HepG2 hepatoma cells and to analyze liver specific expression of IDE in subjects with T2DM. HepG2 cells were treated with 10 nM insulin for 24 h with or without inhibition of IDE activity using IDE RNAi, and cell transcriptome and proliferation rate were analyzed. Human liver samples (n = 22) were used for the gene expression profiling by microarrays. In HepG2 cells, IDE knockdown changed expression of genes involved in cell cycle and apoptosis pathways. Proliferation rate was lower in IDE knockdown cells than in controls. Microarray analysis revealed the decrease of hepatic IDE expression in subjects with T2DM accompanied by the downregulation of the p53-dependent genes FAS and CCNG2, but not by the upregulation of proliferation markers MKI67, MCM2 and PCNA. Similar results were found in the liver microarray dataset from GEO Profiles database. In conclusion, IDE expression is decreased in liver of subjects with T2DM which is accompanied by the dysregulation of p53 pathway. Prolonged use of IDE inhibitors for T2DM treatment should be carefully tested in animal studies regarding its potential effect on hepatic tumorigenesis. | ||
| 650 | 4 | |a hepatocellular carcinoma | |
| 650 | 4 | |a insulin-degrading enzyme | |
| 650 | 4 | |a non-alcoholic fatty liver disease | |
| 650 | 4 | |a proliferation | |
| 650 | 4 | |a type 2 diabetes mellitus | |
| 700 | 1 | |a Sticht, Carsten |d 1972- |e VerfasserIn |0 (DE-588)1020115718 |0 (DE-627)691110077 |0 (DE-576)250042177 |4 aut | |
| 700 | 1 | |a Gretz, Norbert |d 1954-2023 |e VerfasserIn |0 (DE-588)1020104589 |0 (DE-627)691105154 |0 (DE-576)359544843 |4 aut | |
| 700 | 1 | |a Dooley, Steven |d 1960- |e VerfasserIn |0 (DE-588)1028589190 |0 (DE-627)73128951X |0 (DE-576)376074116 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cell cycle |d Abingdon : Taylor & Francis Group, 2002 |g 14(2015), 14, Seite 2293-2300 |h Online-Ressource |w (DE-627)36373368X |w (DE-600)2102687-7 |w (DE-576)261570536 |x 1551-4005 |7 nnas |a Modulation of insulin degrading enzyme activity and liver cell proliferation |
| 773 | 1 | 8 | |g volume:14 |g year:2015 |g number:14 |g pages:2293-2300 |g extent:8 |a Modulation of insulin degrading enzyme activity and liver cell proliferation |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/15384101.2015.1046647 |x Verlag |x Resolving-System |z teilw. kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://doi.org/10.1080/15384101.2015.1046647 |x Verlag |z teilw. kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180130 | ||
| 993 | |a Article | ||
| 994 | |a 2015 | ||
| 998 | |g 1028589190 |a Dooley, Steven |m 1028589190:Dooley, Steven |d 60000 |d 61100 |e 60000PD1028589190 |e 61100PD1028589190 |k 0/60000/ |k 1/60000/61100/ |p 17 | ||
| 998 | |g 1020104589 |a Gretz, Norbert |m 1020104589:Gretz, Norbert |d 60000 |d 999811 |e 60000PG1020104589 |e 999811PG1020104589 |k 0/60000/ |k 1/60000/999811/ |p 16 | ||
| 998 | |g 1020115718 |a Sticht, Carsten |m 1020115718:Sticht, Carsten |d 60000 |d 999811 |e 60000PS1020115718 |e 999811PS1020115718 |k 0/60000/ |k 1/60000/999811/ |p 4 | ||
| 999 | |a KXP-PPN1567859127 |e 2994600595 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"8 S."}],"origin":[{"dateIssuedDisp":"17 Jun 2015","dateIssuedKey":"2015"}],"note":["Gesehen am 30.01.2018"],"id":{"doi":["10.1080/15384101.2015.1046647"],"eki":["1567859127"]},"relHost":[{"part":{"year":"2015","issue":"14","text":"14(2015), 14, Seite 2293-2300","extent":"8","pages":"2293-2300","volume":"14"},"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.2002 -"],"origin":[{"publisherPlace":"Abingdon ; Georgetown, Tex","publisher":"Taylor & Francis Group ; Landes Bioscience","dateIssuedKey":"2002","dateIssuedDisp":"2002-"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2102687-7"],"eki":["36373368X"],"issn":["1551-4005"]},"recId":"36373368X","note":["Gesehen am 23.05.25"],"language":["eng"],"title":[{"title":"Cell cycle","title_sort":"Cell cycle"}],"disp":"Modulation of insulin degrading enzyme activity and liver cell proliferationCell cycle"}],"recId":"1567859127","person":[{"display":"Pivovarova-Ramich, Olga","family":"Pivovarova-Ramich","roleDisplay":"VerfasserIn","role":"aut","given":"Olga"},{"role":"aut","roleDisplay":"VerfasserIn","family":"Sticht","display":"Sticht, Carsten","given":"Carsten"},{"given":"Norbert","role":"aut","roleDisplay":"VerfasserIn","family":"Gretz","display":"Gretz, Norbert"},{"roleDisplay":"VerfasserIn","role":"aut","display":"Dooley, Steven","family":"Dooley","given":"Steven"}],"language":["eng"],"name":{"displayForm":["Olga Pivovarova, Christian von Loeffelholz, Iryna Ilkavets, Carsten Sticht, Sergei Zhuk, Veronica Murahovschi, Sonja Lukowski, Stephanie Döcke, Jennifer Kriebel, Tonia de las Heras Gala, Anna Malashicheva, Anna Kostareva, Johan F. Lock, Martin Stockmann, Harald Grallert, Norbert Gretz, Steven Dooley, Andreas F.H. Pfeiffer, and Natalia Rudovich"]},"title":[{"title":"Modulation of insulin degrading enzyme activity and liver cell proliferation","title_sort":"Modulation of insulin degrading enzyme activity and liver cell proliferation"}]} | ||
| SRT | |a PIVOVAROVAMODULATION1720 | ||